Carnosic Acid Attenuates Cadmium Induced Nephrotoxicity by Inhibiting Oxidative Stress, Promoting Nrf2/HO-1

Sonjit Das1, Saikat Dewanjee1, Tarun K Dua1

  • 1Advanced Pharmacognosy Research Laboratory, Department of Pharmaceutical Technology, Jadavpur University, Kolkata 700032, India.

Insights

Carnosic acid (CA) protects kidneys from cadmium toxicity by reducing oxidative stress, apoptosis, and fibrosis. This natural antioxidant shows potential as a therapeutic agent against cadmium-induced kidney damage.

Area of Science:

  • Toxicology
  • Pharmacology
  • Biochemistry

Background:

  • Cadmium (Cd) exposure causes kidney damage (nephrotoxicity) through oxidative stress and cellular signaling.
  • Natural compounds are being investigated for protective effects against heavy metal toxicity.

Purpose of the Study:

  • To investigate the protective mechanism of carnosic acid (CA) against cadmium chloride (CdCl2)-induced nephrotoxicity.
  • To evaluate CA's efficacy in both in vitro and in vivo models.

Main Methods:

  • In vitro assays using normal kidney epithelial (NKE) cells and in vivo studies in mice.
  • Assessment of cell viability, oxidative stress markers, apoptosis, fibrosis, and renal function parameters.
  • Molecular docking to predict interactions between CA and key signaling molecules.

Main Results:

  • CdCl2 induced oxidative stress, apoptosis, and fibrosis in renal cells by inhibiting Nrf2 and activating TGF-β1/Smad/collagen IV pathways.
  • CA treatment attenuated CdCl2-induced nephrotoxicity by reducing free radicals, enhancing redox defense, suppressing apoptosis, and inhibiting fibrosis.
  • CA improved blood and urine parameters in mice and showed protective effects in histological analyses.
  • Molecular docking suggested interactions between CA and Nrf2, TGF-β1, Smad, and collagen IV.

Conclusions:

  • Carnosic acid exhibits significant protective effects against cadmium-induced nephrotoxicity.
  • CA acts by mitigating oxidative stress, apoptosis, and fibrosis through modulation of key signaling pathways.
  • CA is a promising therapeutic candidate for treating cadmium-mediated kidney damage.